Depression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or ...

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

For Pree, diagnosed with multiple sclerosis at 19, finishing college was a challenge. Still, amidst it all, she decided to open up about her journey by sharing her first video on YouTube. Little did ...

Ageing is associated with significant immunological changes that can influence both the progression of the disease and the ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

Christina Applegate got emotional opening up about her struggle with multiple sclerosis, nearly four years after she was ...

Columnist Desiree Lama shares what she wishes she'd been told after her diagnosis of multiple sclerosis at age 17.

Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...

Keeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS).

A University of Alberta study shows that rural Albertans living with multiple sclerosis are not as likely as urban patients ...

Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral ...